epilepsy
Showing NaN - NaN of 50
Epilepsy, Dravet Syndrome Trial in Worldwide (GWP42003-P 20 mg/kg/day Dose, Placebo control)
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P 20 mg/kg/day Dose
- Placebo control
-
Miami, Florida
- +21 more
Jul 26, 2018
Epilepsy, Dravet Syndrome Trial in United Kingdom, United States (GWP42003-P 5 mg/kg/day Dose, Placebo control, GWP42003-P 10
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P 5 mg/kg/day Dose
- +3 more
-
Miami, Florida
- +10 more
Jul 26, 2018
Epilepsy, Lennox-Gastaut Syndrome Trial in Netherlands, Poland, United States (GWP42003-P 20 mg/kg/day Dose, Placebo)
Completed
- Epilepsy
- Lennox-Gastaut Syndrome
- GWP42003-P 20 mg/kg/day Dose
- Placebo
-
Tampa, Florida
- +23 more
Jul 26, 2018
Epilepsy, MDD (MDD) Trial in United States (Extended-release bupropion (HCl))
Completed
- Epilepsy
- Major Depressive Disorder (MDD)
- Extended-release bupropion (HCl)
-
Beverly Hills, California
- +23 more
May 24, 2017
Epilepsy, Tuberous Sclerosis Complex Trial in Cincinnati, Houston (Everolimus)
Completed
- Epilepsy
- Tuberous Sclerosis Complex
-
Cincinnati, Ohio
- +1 more
Feb 1, 2017
Epilepsy, Epilepsy, Partial Trial in Worldwide (LAMICTAL extended-release)
Completed
- Epilepsy
- Epilepsy, Partial
- LAMICTAL extended-release
-
Anniston, Alabama
- +147 more
Dec 2, 2016
Epilepsy, Depressive Symptoms, Depression Trial in United States (Project UPLIFT)
Completed
- Epilepsy
- +3 more
- Project UPLIFT
-
Atlanta, Georgia
- +3 more
Feb 11, 2014
Epilepsy Trial in United States (RNS® System implantation, RNS® System responsive stimulation)
Completed
- Epilepsy
- RNS® System implantation
- RNS® System responsive stimulation
-
Birmingham, Alabama
- +31 more
Aug 23, 2013
Epilepsy, Epilepsy, Generalized, Seizures Trial in Worldwide (Clobazam Low Dose, Clobazam Medium Dose, Clobazam High Dose)
Completed
- Epilepsy
- +2 more
- Clobazam Low Dose
- +3 more
-
Huntsville, Alabama
- +52 more
Jan 6, 2012
